United Kingdom · Venture startup

Who invested in Neurovalens

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 6 months ago

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2026, from 1 source

Latest round
VentureMay 2026
Investors
3
See who backed them

The rounds

  1. May 2026
    VentureAmount undisclosed

    Source recorded

Everyone who backed them

IQ CapitalVC firm1round
ACF InvestorsVC firm1round
British Business BankCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Neurovalens

Who invested in Neurovalens?

Neurovalens's investors include IQ Capital, ACF Investors and British Business Bank.

How much has Neurovalens raised?

Neurovalens has raised 1 round since 2026, none with a disclosed amount.

When did Neurovalens last raise?

Neurovalens's most recent round was a Venture in May 2026.

Who backed Neurovalens first?

Neurovalens's first round on record, in May 2026, was backed by IQ Capital, ACF Investors and British Business Bank.

What stage is Neurovalens at?

Neurovalens's latest named round is a Venture, in May 2026.

Where is Neurovalens based?

Neurovalens is based in the United Kingdom.

Companies like Neurovalens

In the same sector, and raised in the last eighteen months.

HydRegen$12M · Oct 2026OMass Therapeutics$442M · Oct 2026CMR Surgical$1.1B · Oct 2026Living Optics$61M · Oct 2026Bactobio$18M · Oct 2026RHYTHM AI$23M · Sept 2026

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app